Cidara Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cidara Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q3 2024.
  • Cidara Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$16M, a 75.5% decline year-over-year.
  • Cidara Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$121M, a 262% decline year-over-year.
  • Cidara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$22.9M, a 31.7% increase from 2022.
  • Cidara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$33.6M, a 20.9% increase from 2021.
  • Cidara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$42.5M, a 41.1% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$121M -$16M -$6.88M -75.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$114M -$91.2M -$77.6M -569% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$36.3M -$10.3M -$13.3M -443% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$22.9M -$3.21M +$10.4M +76.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-22
Q3 2023 -$33.3M -$9.11M -$23.4M -164% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$9.96M -$13.6M +$2.14M +13.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$12.1M $3.01M +$21.5M Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$33.6M -$13.6M +$3.21M +19.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-22
Q3 2022 -$36.8M $14.2M +$32.3M Jul 1, 2022 Sep 30, 2022 10-K 2024-04-22
Q2 2022 -$69.1M -$15.8M -$26.5M -247% Apr 1, 2022 Jun 30, 2022 10-K 2024-04-22
Q1 2022 -$42.6M -$18.5M -$182K -1% Jan 1, 2022 Mar 31, 2022 10-K 2024-04-22
Q4 2021 -$42.5M -$16.8M +$4.83M +22.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$47.3M -$18.1M -$451K -2.56% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$46.8M $10.7M +$29M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$75.9M -$18.3M -$3.75M -25.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$72.1M -$21.6M -$7.61M -54.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 -$64.5M -$17.6M -$20.7M -680% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$43.8M -$18.3M -$4.76M -35.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$39.1M -$14.5M +$2.02M +12.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$41.1M -$14M -$1.68M -13.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-07
Q3 2019 -$39.4M $3.04M +$16.7M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$56.1M -$13.5M +$2.76M +16.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-05
Q1 2019 -$58.8M -$16.6M +$188K +1.12% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-05
Q4 2018 -$59M -$12.3M +$1.09M +8.09% Oct 1, 2018 Dec 31, 2018 10-K 2019-02-28
Q3 2018 -$60.1M -$13.6M -$1.36M -11.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$58.7M -$16.3M +$339K +2.04% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-08
Q1 2018 -$59.1M -$16.7M -$3.35M -25% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-08
Q4 2017 -$55.7M -$13.4M +$966K +6.71% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$56.7M -$12.3M -$30K -0.25% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$56.7M -$16.6M -$4.89M -41.6% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$51.8M -$13.4M -$3.61M -36.9% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$48.2M -$14.4M -$4.53M -45.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 -$43.6M -$12.2M -$3.05M -33.3% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-27
Q2 2016 -$40.6M -$11.8M -$5.34M -83.3% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-27
Q1 2016 -$35.2M -$9.79M -$3.05M -45.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-27
Q4 2015 -$32.2M -$9.87M -$5.22M -112% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$27M -$9.17M -$5.86M -176% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-15
Q2 2015 -$21.1M -$6.41M -$3.2M -99.3% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-15
Q1 2015 -$17.9M -$6.74M -$6.03M -853% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-15
Q4 2014 -$11.9M -$4.65M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-18
Q3 2014 -$3.32M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-18
Q2 2014 -$3.22M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-18
Q1 2014 -$707K Jan 1, 2014 Mar 31, 2014 10-K 2016-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.